Abbott Laboratories (ABT) Retained Earnings (2009 - 2026)

Abbott Laboratories has disclosed Retained Earnings across 18 years of filings, most recently posting $50.0 billion for Q1 2026.

• Retained Earnings for Q1 2026 came in at $50.0 billion, up 4.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.0 billion (up 4.7% YoY), and the FY2025 annual result was -$6.0 billion, down 112.7% from the prior year.
• Retained Earnings came in at $50.0 billion for Q1 2026 at Abbott Laboratories, up from -$6.0 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $50.0 billion in Q1 2026 to a low of -$8.5 billion in Q3 2023.
• The 5-year median for Retained Earnings is $35.1 billion (2022), against an average of $21.8 billion.
• Across the five-year window, Retained Earnings sank 129.56% in 2022 and surged 702.9% in 2024, its largest moves.
• Abbott Laboratories' Retained Earnings stood at -$8.1 billion in 2022, then gained by 2.63% to -$7.8 billion in 2023, then surged by 702.9% to $47.3 billion in 2024, then tumbled by 112.7% to -$6.0 billion in 2025, then soared by 932.46% to $50.0 billion in 2026.
• The last three Retained Earnings figures came in at $50.0 billion (Q1 2026), -$6.0 billion (Q4 2025), and $49.1 billion (Q3 2025), per Business Quant data.